The relationship between airflow obstruction, emphysema extent, and small airways function in COPD

Chest
Sophie C TimminsGregory G King

Abstract

The severities of COPD (FEV(1) % predicted) and airflow obstruction (FEV(1)/FVC) are considered to be due to both emphysema and small airways disease. To our knowledge, this has not been previously confirmed by combined measurements of emphysema and of small airway function. We hypothesized that small airways disease and emphysema extent contribute independently to the severity of both COPD and airflow obstruction. Twenty-six subjects with COPD underwent measurements with forced oscillation technique (FOT) at 6 Hz and single-breath nitrogen washout. Respiratory system resistance, respiratory system reactance (Xrs), and expiratory flow limitation (EFL) index (measured as mean inspiratory Xrs − expiratory Xrs) were derived from FOT. Closing volume/vital capacity (CV/VC) was derived from the washout. Emphysema extent was measured as low attenuation areas < -910 Hounsfield units, expressed as a percentage of CT scan lung volume from multislice CT scans taken at total lung capacity. Subjects were aged (mean ± SD) 69.6 ± 8.0 years. Postbronchodilator FEV(1) was 64.8 ± 19.8% predicted, and diffusing capacity of lung for carbon monoxide was 50.7 ± 15.8% predicted. Emphysema extent was 22.6% ± 15.0% CT scan volume. CV/VC was 16.9% ± 7.9...Continue Reading

Associated Clinical Trials

References

Jun 8, 1978·The New England Journal of Medicine·M CosioP T Macklem
Sep 1, 1991·Respiratory Medicine·P W JonesC M Baveystock
Jun 1, 1972·The American Journal of Medicine·D S McCarthyJ Milic-Emili
Dec 1, 1969·Respiration Physiology·N R AnthonisenW R Ross
Aug 1, 1995·American Journal of Respiratory and Critical Care Medicine·P A GevenoisJ C Yernault
Feb 1, 1996·Chest·A F GelbL Hadjiaghai
Jul 1, 1996·American Journal of Respiratory and Critical Care Medicine·P A GevenoisJ C Yernault
Oct 14, 1998·American Journal of Respiratory and Critical Care Medicine·A Di StefanoM Saetta
Jan 5, 1999·American Journal of Respiratory and Critical Care Medicine·J L HankinsonK B Fedan
Mar 2, 1999·American Journal of Respiratory and Critical Care Medicine·H O CoxsonJ C Hogg
Sep 16, 2000·American Journal of Respiratory and Critical Care Medicine·Y NakanoM Mishima
Oct 6, 2001·American Journal of Respiratory and Critical Care Medicine·J Garcia-AymerichUNKNOWN EFRAM Investigators
Dec 19, 2003·The European Respiratory Journal·E OostveenUNKNOWN ERS Task Force on Respiratory Impedance Measurements
Feb 26, 2004·The European Respiratory Journal·R Farré, D Navajas
Jun 25, 2004·The New England Journal of Medicine·James C HoggPeter D Paré
Jul 20, 2004·Journal of Applied Physiology·C William ThorpeGregory G King
Nov 2, 2004·American Journal of Respiratory and Critical Care Medicine·Yasutaka NakanoPeter D Paré
Aug 2, 2005·The European Respiratory Journal·M R MillerUNKNOWN ATS/ERS Task Force
Sep 2, 2005·The European Respiratory Journal·J WangerG Viegi
Oct 6, 2005·The European Respiratory Journal·N MacintyreJ Wanger
Mar 22, 2006·Respiratory Medicine·Yoshiaki KitaguchiTakayuki Honda
May 18, 2007·American Journal of Respiratory and Critical Care Medicine·Klaus F RabeUNKNOWN Global Initiative for Chronic Obstructive Lung Disease
Jun 3, 2008·Trends in Pharmacological Sciences·Graham SturtonPeter J Barnes
May 5, 2009·Chest·Woo Jin KimUNKNOWN NETT Research Group
Nov 21, 2009·American Journal of Respiratory and Critical Care Medicine·Thomas B GrydelandPer S Bakke
Feb 16, 2011·Respiratory Physiology & Neurobiology·Paul D RobinsonGreg G King
Apr 13, 2011·Respiratory Medicine·Courtney CrimUNKNOWN ECLIPSE investigators

❮ Previous
Next ❯

Citations

Oct 18, 2012·Pulmonary Pharmacology & Therapeutics·Nicola ScichiloneNicola Sverzellati
Apr 2, 2015·Respirology : Official Journal of the Asian Pacific Society of Respirology·Stephen Milne, Gregory G King
Jan 13, 2015·European Radiology·Stefan F NemecAlexander A Bankier
Jul 3, 2013·Respiratory Physiology & Neurobiology·Masashi MikamoTakafumi Suda
Jul 24, 2013·Respiratory Physiology & Neurobiology·Kate M HardakerCheryl M Salome
Dec 30, 2014·Bio Systems·P H MasonA Grignolio
Feb 21, 2014·BMC Pulmonary Medicine·Masashi MikamoTakafumi Suda
Mar 4, 2014·BMC Pulmonary Medicine·Sébastien BommartHélène Vernhet-Kovacsik
Nov 16, 2017·Respirology : Official Journal of the Asian Pacific Society of Respirology·Kanika JetmalaniGregory G King
Jun 4, 2015·Therapeutic Advances in Respiratory Disease·Matteo Bonini, Omar S Usmani
Apr 25, 2018·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Joshua GawlitzaThomas Henzler
Nov 7, 2015·The European Respiratory Journal·Megan HardinUNKNOWN COPDGene Investigators
Sep 2, 2015·The European Respiratory Journal·Erik Folch, Gunnar Hillerdal
Nov 15, 2013·Expert Review of Respiratory Medicine·Christian R OsadnikAnne E Holland
Aug 29, 2017·PloS One·Claudia LlontopFrancisco García-Río
Jul 10, 2019·European Respiratory Review : an Official Journal of the European Respiratory Society·Thibaut CapronPascal Chanez
Feb 27, 2021·Scientific Reports·Daniele Oliveira Dos SantosAda Clarice Gastaldi
Feb 26, 2021·International Journal of Chronic Obstructive Pulmonary Disease·Priyamvada S ChukowryAlice M Turner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.